ABSTRACT
Recently, compound Ejiao slurry (FFEJJ) had been applied to treat cancer patients in clinic, with obvious curative effect. In this study, data and literatures were collected from the TCM chemical component database to establish the chemical component database of FFEJJ. Afterwards, MetaDrug software was used to predict the targets of FFEJJ and obtain the compound-target network. Next, the compound-target network was compared and analyzed to obtain the "compound-target-tumor target" heterogeneous network. Besides, further analysis was made on gene functions and metabolic pathway. The results indicated that FFEJJ could directly resist tumors by regulating cancer cell differentiation, growth, proliferation and apoptosis, and show an adjuvant therapeutic effect by enriching the blood and increasing the immunity.
Subject(s)
Adjuvants, Pharmaceutic/therapeutic use , Antineoplastic Agents/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Gene Regulatory Networks/drug effects , Neoplasms/drug therapy , Neoplasms/genetics , Humans , Molecular Targeted Therapy , Neoplasms/metabolismABSTRACT
A wide range of pharmacological and clinical studies have been made on compound Ejiao Jiang in enriching blood, enhancing white blood cell, adjuvant chemotherapy, et al. By reference to relevant documents, this study summarizes current researches on compound Ejiao Jiang in terms of pharmacological and clinical application, providing literature basis for further studies on compound Ejiao Jiang.